EVENTS | VIEW CALENDAR
Life-science companies launch rare disease research competition
SAN DIEGOŚAssay Depot and Rare Genomics Institute announced Oct. 15 that they have partnered with 19 life science companies to launch the first Rare Disease Science Challenge: Helping Empower and Accelerate Research Discoveries, or "Be HEARD."
The hosts and sponsoring organizations are supporting rare disease research by donating $400,000 in cutting edge technology, services and resources, as well as a $10,000 cash prize to the winning research proposal.
Be HEARD encourages non-profits, academic researchers, rare disease advocacy groups, families of rare disease patients and for-profit companies to collaborate to advance rare disease research.
"This competition brings the life science community together to study rare diseases in an unprecedented opportunity to empower afflicted families and underfunded researchers," says Kevin Lustig, CEO of Assay Depot. "Ultimately, we want the voices of rare disease to be heard, while helping to accelerate the science behind a cure."
Research proposals can be submitted from until Dec. 15 for any or all of the nearly 20 donated services. An expert scientific panel will select the winner for each donation.
For more information, visit http://challenge.assaydepot.com/rare- disease-challenge.
Other sponsors of Be HEARD include Biopta, Charles River Laboratories, DNA Software, HistoRx, Ingenuity Systems and Taconic. Media partners include Ben's Friends, Drug Discovery News, Drug Discovery and Development, Global Genes R.A.R.E. Project, Global Healthy Living Foundation and Mendelspod.
"We are amazed by the generosity of so many companies offering their expertise, services, consulting and reagents to help advance rare disease research," says Jimmy Lin, President of Rare Genomics Institute. "We hope this gives a boost to rare diseases research and jump starts research in diseases that are otherwise not studied."